Table 7.
Sl no | Target | Chloroquine |
Isothymol |
beta-D-Mannose |
Captopril |
Thymol |
limonene |
p-cymene |
γ-terpinene |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Probability | Prediction | Probability | Prediction | Probability | Prediction | Probability | Prediction | Probability | Prediction | Probability | Prediction | Probability | Prediction | Probability | Prediction | ||
01 | Immunotoxicity | 0.96 | Active | 0.89 | Inactive | 0.96 | Active | 0.96 | Active | 0.93 | Inactive | 0.96 | Active | 0.96 | Active | 0.96 | Active |
02 | Cytotoxicity | 0.93 | Inactive | 0.70 | Inactive | 0.93 | Inactive | 0.93 | Inactive | 0.89 | Inactive | 0.93 | Inactive | 0.93 | Inactive | 0.93 | Inactive |
03 | Mutagenicity | 0.97 | Inactive | 0.84 | Inactive | 0.97 | Inactive | 0.97 | Inactive | 0.99 | Inactive | 0.97 | Inactive | 0.97 | Inactive | 0.97 | Inactive |
04 | Carcinogenicity | 0.62 | Inactive | 0.62 | Inactive | 0.62 | Inactive | 0.62 | Inactive | 0.60 | Inactive | 0.62 | Inactive | 0.62 | Inactive | 0.62 | Inactive |
05 | Phosphoprotein (Tumor Supressor) p53 | 0.96 | Inactive | 0.97 | Inactive | 0.96 | Inactive | 0.96 | Inactive | 0.96 | Inactive | 0.96 | Inactive | 0.96 | Inactive | 0.96 | Inactive |